Production (Stage)
Connect Biopharma Holdings Limited
CNTB
$0.9301
-$0.0199-2.10%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | 0.00% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | 0.00% | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | 0.00% | |||
| SG&A Expenses | -18.41% | 0.00% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | 0.00% | |||
| Total Operating Expenses | -24.47% | 0.00% | |||
| Operating Income | 19.37% | 0.00% | |||
| Income Before Tax | 11.59% | 0.00% | |||
| Income Tax Expenses | -33.74% | 0.00% | |||
| Earnings from Continuing Operations | 11.74% | 0.00% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 11.74% | 0.00% | |||
| EBIT | 19.37% | 0.00% | |||
| EBITDA | 19.69% | 0.00% | |||
| EPS Basic | 11.83% | 0.00% | |||
| Normalized Basic EPS | 14.83% | 0.00% | |||
| EPS Diluted | 12.33% | 0.00% | |||
| Normalized Diluted EPS | 14.83% | 0.00% | |||
| Average Basic Shares Outstanding | 0.13% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.13% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||